Globorisk – nowa uniwersalna skala oceny ryzyka sercowo-naczyniowego. W jakich krajach ryzyko jest największe a w jakich najmniejsze?

Kaveh Hajifathalian i wsp – A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys The Lancet Diabetes & Endocrinology online
The prevalence of people at high risk of fatal cardiovascular disease was lowest in South Korea, Spain, and Denmark, where only 5–10% of men and women had more than a 10% risk, and 62–77% of men and 79–82% of women had less than a 3% risk. Conversely, the proportion of people at high risk of fatal cardiovascular disease was largest in China and Mexico. In China, 33% of men and 28% of women had a 10-year risk of fatal cardiovascular disease of 10% or more, whereas in Mexico, the prevalence of this high risk was 16% for men and 11% for women …

Opracowane na podstawie: The Lancet Diabetes & Endocrinology online / 25 marca 2015